Kathleen L. Tivel

Statistics

Publications

Citations

793

H-Index

Active since

1993

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Pfizer (United States)

Kathleen L. Tivel is an author at Ionis Pharmaceuticals (United States) specializing in pharmacy, oligonucleotide chemistry, and molecular pharmacology.

Publications per year

1993–2004

Publications

Pharmacokinetic properties of several novel oligonucleotide analogs in mice.

Stanley T. Crooke, Melissa Graham, J E Zuckerman et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 228 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Base-Sequence Dependence of Emission Lifetimes for D141018-30-6NA Oligomers and Duplexes Covalently Labeled with Pyrene: Relative Electron-Transfer Quenching Efficiencies of A, G, C, and T Nucleosides toward Pyrene

Muthiah Manoharan, Kathleen L. Tivel, Min Zhao et al. · The Journal of Physical Chemistry · 1995 · 181 citations

Natural Sciences, Chemistry, Physics +9

Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.

Suresh K. Alahari, Nicholas M. Dean, M. H. FISHER et al. · Molecular Pharmacology · 1996 · 97 citations

Medicine, Oncology, Pharmacology +14

SFC/MS in drug discovery at Pfizer, La Jolla

Ben Bolaños, Michael J. Greig, Manuel Ventura et al. · International Journal of Mass Spectrometry · 2004 · 88 citations

Pharmacy, Pharmacokinetics, Pharmacology +4

High-throughput preparative process utilizing three complementary chromatographic purification technologies

Manuel Ventura, William Farrell, Christine M. Aurigemma et al. · Journal of Chromatography A · 2004 · 46 citations

Pharmacy, Biochemistry, Chemical Engineering +14

1–5 of 11